NeuWrite Nordic – Bringing together scientists and writers
Description: Tim Requarth is a freelance journalist and Lecturer in Science and Writing at NYU.
Last week, the Food and Drug Administration ignored the advice of its own expert advisory committee and approved the first new treatment for Alzheimer’s in 18 years. Called Aduhelm, it carries a substantial risk of painful brain swelling and bleeding, requires monthly infusions, and comes with an eye-popping list price of $56,000 per year. These caveats might be fine if the drug, which is manufactured by Biogen, miraculously restored the memories lost by the 6 million Americans with Alzheimer’s—or at least
Across social media, Silicon Valley data wonks, as well as people with Ph.D.s in fields tangentially related to epidemiology, are analyzing public datasets, posting graphs, and making sweeping predictions about the pandemic. Some, like Ginn, draw conclusions that contradict accepted public health advice. Other casual assessments of the numbers are being used to make uselessly terrifying cases for containing the virus’s spread. Wherever you look, people have become suspiciously comfortable with concepts like
New York state corrections officials believe that approximately 2,000 prisoners were subject to a flawed drug test that produced false positives and led to increased punishment across the state, according to documents obtained by WNYC/Gothamist. Read more…
NeuWrite Nordic – Bringing together scientists and writers